Norton Rose Fulbright lawyers Kristin Wall, Randy Sutton, Veronique Barry, Christopher Guerreiro and Sarah Pennington contributed the Canada chapters to the Practical Law Life Sciences Global Guide on commercialization and regulation. The Guide is published in a Q&A format by Thomson Reuters, which is a leading global platform for trusted, up-to-date legal know how across all major practice areas.

Life Sciences Commercialisation in Canada: Overview

The Q&A Guide to life sciences commercialisation in Canada provides an overview of Canada’s life sciences sector, pricing and state funding, distribution and sale, importing, advertising, patents, trade marks, competition law, and product liability.

Life Sciences Regulation in Canada: Overview

The Q&A guide to life sciences regulation in Canada reviews the main legislation governing pharmaceuticals in Canada. The guide provides an overview of key practical issues, including clinical trials, manufacturing, marketing, abridged procedures, pharmacovigilance, data privacy, packaging and labelling, biological medicines, medical devices, health care IT, combination products, and natural health products.



Contacts

Kristin Wall
Kristin Wall
Partner, Lawyer, Trademark Agent
Email
kristin.wall@nortonrosefulbright.com
T: +1 416 216 3964
Randy Sutton
Randy Sutton
Global Co-Head of Life Sciences and Healthcare; Partner
Email
randy.sutton@nortonrosefulbright.com
T: +1 416 216 4046
Véronique Barry
Véronique Barry
Partner
Email
veronique.barry@nortonrosefulbright.com
T: +1 418 640 5170
Christopher A. Guerreiro
Christopher A. Guerreiro
Of Counsel
Email
christopher.guerreiro@nortonrosefulbright.com
T: +1 416 216 1938
Sarah Pennington
Sarah Pennington
Associate
Email
sarah.pennington@nortonrosefulbright.com
T: +1 416 216 4770

Practice areas:

Recent publications

Federal building

Publication

The Industrial and Technological Benefits Policy: A primer on a key feature of the Canadian national security and defence landscape

Recent announcements by the Canadian federal government to invest billions of dollars to modernize the Canadian Armed Forces, build a self-sufficient domestic defence and security industrial base, and reduce reliance on the United States for defence capabilities signal Canada’s renewed commitment to national defence and security and a diversification of its strategic alliances.

Canada | July 3, 2025

Government relations and public policy
Bright Buildings

Publication

Beyond the ballot: A look at proxy season 2025 shareholder proposals

Even when shareholder proposals fall short at the polls, their influence can resonate beyond the vote count and plant the seed for potential shifts in shareholder engagement themes.

Canada | July 3, 2025

Corporate, M&A and securities
Abstract-orange-and-blue-building

Publication

OSC proposes to restrict short sellers from participating in distributions of reporting issuers in Ontario

The Ontario Securities Commission (OSC) is seeking public comment until September 3, 2025, on a proposal (the Proposal) to prohibit persons and companies from participating in prospectus offerings and private placements made by reporting issuers in Ontario when such persons or companies recently sold short the equity security being offered.

Canada | July 2, 2025

Corporate, M&A and securities
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now